Takeda and Cardurion Pharmaceuticals Launch Cardiovascular Development Partnership
Collaboration to develop novel, next-generation therapeutics to treat heart disease Osaka, Japan and Cambridge, Mass., – 2 August 2017 – Takeda Pharmaceutical Company Limited (TSE: 4502) and Cardurion Pharmaceuticals today announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is focused on the development of novel, next-generation […]
